INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 120 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $41,818 | -74.4% | 50,998 | -51.2% | 0.00% | – |
Q4 2022 | $163,148 | +0.7% | 104,582 | +11.5% | 0.00% | – |
Q3 2022 | $162,000 | -43.4% | 93,822 | -43.2% | 0.00% | – |
Q2 2022 | $286,000 | -50.4% | 165,053 | +2.7% | 0.00% | – |
Q1 2022 | $577,000 | -28.1% | 160,739 | 0.0% | 0.00% | – |
Q4 2021 | $802,000 | -30.3% | 160,739 | 0.0% | 0.00% | – |
Q3 2021 | $1,151,000 | +3.6% | 160,739 | +34.1% | 0.00% | – |
Q2 2021 | $1,111,000 | -3.7% | 119,878 | -3.7% | 0.00% | – |
Q1 2021 | $1,154,000 | +35.1% | 124,451 | +29.0% | 0.00% | – |
Q4 2020 | $854,000 | -23.8% | 96,510 | -0.2% | 0.00% | -100.0% |
Q3 2020 | $1,121,000 | -5.0% | 96,688 | +120.8% | 0.00% | 0.0% |
Q2 2020 | $1,180,000 | +642.1% | 43,788 | +104.2% | 0.00% | – |
Q1 2020 | $159,000 | +82.8% | 21,445 | -18.7% | 0.00% | – |
Q4 2019 | $87,000 | +67.3% | 26,365 | +3.8% | 0.00% | – |
Q3 2019 | $52,000 | -8.8% | 25,409 | +30.7% | 0.00% | – |
Q2 2019 | $57,000 | -5.0% | 19,438 | +19.5% | 0.00% | – |
Q1 2019 | $60,000 | -1.6% | 16,263 | +6.8% | 0.00% | – |
Q4 2018 | $61,000 | -15.3% | 15,232 | +18.3% | 0.00% | – |
Q3 2018 | $72,000 | +41.2% | 12,877 | 0.0% | 0.00% | – |
Q2 2018 | $51,000 | -27.1% | 12,877 | -13.1% | 0.00% | – |
Q1 2018 | $70,000 | -18.6% | 14,815 | -29.2% | 0.00% | – |
Q4 2017 | $86,000 | -34.8% | 20,919 | 0.0% | 0.00% | – |
Q3 2017 | $132,000 | +3.9% | 20,919 | +29.6% | 0.00% | – |
Q2 2017 | $127,000 | +19.8% | 16,135 | 0.0% | 0.00% | – |
Q1 2017 | $106,000 | -6.2% | 16,135 | -1.1% | 0.00% | – |
Q4 2016 | $113,000 | +59.2% | 16,312 | +112.2% | 0.00% | – |
Q3 2016 | $71,000 | -41.3% | 7,688 | -41.8% | 0.00% | – |
Q2 2016 | $121,000 | +1.7% | 13,204 | 0.0% | 0.00% | – |
Q1 2016 | $119,000 | +43.4% | 13,204 | +10.0% | 0.00% | – |
Q4 2015 | $83,000 | +18.6% | 11,999 | 0.0% | 0.00% | – |
Q3 2015 | $70,000 | -20.5% | 11,999 | +9.4% | 0.00% | – |
Q2 2015 | $88,000 | +22.2% | 10,973 | +23.9% | 0.00% | – |
Q1 2015 | $72,000 | -12.2% | 8,853 | 0.0% | 0.00% | – |
Q4 2014 | $82,000 | -5.7% | 8,853 | 0.0% | 0.00% | – |
Q3 2014 | $87,000 | – | 8,853 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |